TAMPERE, Finland, Aug. 16, 2023 /PRNewswire/ — Bioretec Ltd, a pioneering firm devoted to advancing orthopedic biodegradable implants, has refined and expanded its esteemed Scientific Advisory Board (SAB). To additional strengthen its strategic focus areas, Bioretec has assembled a distinguished group of key opinion leaders to signify experience from the refocused RemeOs™ portfolio. These top-tier consultants and surgeons, famend for his or her important contributions to orthopedics and medical analysis, will type Bioretec’s Scientific Advisory Board.
These eminent surgeons, specializing in orthopedic trauma (Prof. Dr. Klaus Dresing[i], Germany and Prof. Dr. Fan Liu[ii], China), foot and ankle surgical procedure (Prof. Dr. Stefan Rammelt[iii], Germany and Dr. Robert Leland[iv], USA), pediatric orthopedic trauma (Prof. Dr. Theddy Slongo[v], Switzerland and Dr. Verena Schreiber[vi], USA) and spine surgical procedure (Prof. Dr. Jeffrey Wang[vii], USA and Dr. Richard Assaker[viii], France), have been rigorously chosen to type Bioretec’s high-powered SAB. Greater than only a group of huge names, the SAB will play an integral function in guiding the corporate’s processes relating to scientific product growth, schooling and coaching applications, and fascinating surgeon communities.
Bioretec is poised to rework orthopedic surgical observe with its new cutting-edge know-how. The RemeOs™ product line represents a significant milestone, providing a breakthrough resolution that mixes the advantages of biodegradability, implant power, and efficiency. This remodeling know-how not solely ensures efficient remedy but additionally eliminates the necessity for subsequent implant elimination surgical procedures, thereby enhancing affected person consolation and lowering healthcare prices.
Bioretec’s dedication to excellence extends past its revolutionary merchandise. Actively involving key opinion leaders within the pre- and postmarket processes, Bioretec ensures that its options meet the evolving wants and expectations of medical professionals. This collaborative method ensures that surgeons and healthcare professionals stay on the forefront of developments within the discipline.
The Scientific Advisory Board will work carefully with Bioretec’s government group, contributing their helpful views and data to advance the corporate’s analysis, growth, and scientific methods. Their collective insights, mixed with their affect inside the medical group, will empower Bioretec to push the boundaries of orthopedic innovation, finally benefiting sufferers worldwide.
Timo Lehtonen, the CEO of Bioretec, expresses his gratitude for the help acquired from these famend worldwide surgeons, stating, “It’s crucial for Bioretec to have gained the help of key opinion leaders in numerous disciplines. We’re subsequently very honored that such a distinguished group of surgeons belief Bioretec and our new RemeOs™ product line to set a brand new customary within the orthopedic trade. By harnessing the collective experience of the SAB, Bioretec goals to realize the potential to drive important enhancements in scientific efficiency and affected person expertise. Their mixed experience and imaginative and prescient align seamlessly with Bioretec’s mission to enhance affected person’s high quality of life via revolutionary orthopedic options,” Lehtonen continues.
Timo Lehtonen, CEO, tel. +358 50 433 8493
Johanna Salko, CFO, tel. +358 40 754 8172
Bioretec is a globally working Finnish medical gadget firm that continues to pioneer the applying of biodegradable orthopedic implants. The corporate has constructed distinctive competencies within the organic interface of energetic implants to boost bone progress and speed up fracture therapeutic after orthopedic surgical procedure. The merchandise developed and manufactured by Bioretec are used worldwide in roughly 40 international locations.
Bioretec is growing the brand new RemeOs™ product line based mostly on a magnesium alloy and hybrid composite, introducing a brand new era of robust bioresorbable supplies for enhanced surgical outcomes. The RemeOs™ implants are resorbed and changed by bone, which eliminates the necessity for elimination surgical procedure whereas facilitating fracture therapeutic. The mix has the potential to make titanium implants redundant and assist clinics attain their Worth-Primarily based Healthcare targets whereas specializing in worth for sufferers via environment friendly healthcare. The primary RemeOs™ product market authorization has been acquired within the U.S. in March 2023, and in Europe, CE-mark is predicted to be acquired throughout 2023. Bioretec is positioning itself to enter the addressable USD 7 billion international orthopedic trauma market and turn into a sport changer in surgical bone fracture remedy.
Higher therapeutic – Higher life. www.bioretec.com
[i]Prof. Dr. Klaus Dresing (Chairman): Former Vice Director of the Division of Trauma Surgical procedure, Orthopedics, and Plastic Surgical procedure at Göttingen College Medical Heart in Germany. Quite a few earlier management positions in AO Basis.
[ii]Prof. Dr. Fan Liu: Chief and Professor within the Division of Orthopedic Surgical procedure on the Affiliated Hospital to Nantong College in China. Vice President of the Chinese language Orthopedic Affiliation and the Chinese language Affiliation of Orthopedic Surgeons.
[iii]Prof. Dr. Stefan Rammelt: Professor and Head of the Foot & Ankle Part, College Heart of Orthopaedics & Traumatology, College Hospital Carl Gustav Carus, Dresden, Germany. President, German Society of Biomaterials. Vice-President, German Foot & Ankle Society.
[iv]Dr. Robert Leland: Medical Assistant Professor within the Division of Orthopedics on the College of Colorado, USA. Member of the Colorado Medical Society, American Orthopaedic Foot and Ankle Society, American Academy of Orthopaedic Surgeons, and AO Alumni.
[v]Dr. Verena Schreiber: Pediatric orthopedic surgeon on the Nicklaus Kids’s Hospital Orthopedic, Sports activities Health, and Backbone Institute, Miami, USA. Member of the Pediatric Orthopaedic Society of North America, Orthopaedic Analysis Society, Orthopaedic Trauma Affiliation, American Academy of Orthopaedic Surgeons, American Academy for Cerebral Palsy and Developmental Drugs.
[vi]Prof. Dr. Theddy Slongo: Head of Pediatric Surgical procedure and Baby Traumatology college hospital of Bern, Switzerland. Member and founding father of AO Basis’s Pediatric Knowledgeable Group and Chairman of the Exterior Fixator knowledgeable group of AO Basis
[vii]Prof. Dr. Jeffrey Wang: Professor of Orthopedic Surgical procedure and Neurosurgery, Co-Director of the USC Backbone Heart, Los Angeles, USA. Quite a few management roles in internationally revered medical organizations, together with AO Backbone, the North American Backbone Society NASS, the Cervical Backbone Analysis Society, the American Academy of Orthopedic Surgeons. a Second Medical Opinion Doctor with the Nationwide Hockey League (NHL), and the Nationwide Hockey League Gamers’ Affiliation (NHLPA).
[viii]Prof. Dr. Richard Assaker: Professor of Neurosurgery at CHRU Lille, Hôpital Salengro in Lille, France. Member of the French Society of Neurosurgery, Member of the French Society of Backbone Surgical procedure, member of the Backbone Societies of Europe SSE, Member of the North American Backbone Societies NASS, Member of the Worldwide Instructional Committee of the NASS, Chairman of the worldwide schooling residents program.